ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,105,668 | -11.5% | 115,166 | +14.5% | 1.05% | +1.1% |
| Q2 2023 | $4,640,909 | +8.9% | 100,605 | -5.3% | 1.04% | +0.5% |
| Q1 2023 | $4,261,908 | +102.1% | 106,282 | +133.5% | 1.03% | +114.3% |
| Q4 2022 | $2,108,942 | +11.9% | 45,520 | 0.0% | 0.48% | -0.8% |
| Q3 2022 | $1,885,000 | -31.7% | 45,520 | -1.5% | 0.49% | -21.2% |
| Q2 2022 | $2,758,000 | -17.8% | 46,221 | 0.0% | 0.62% | -15.4% |
| Q1 2022 | $3,357,000 | -60.5% | 46,221 | -57.5% | 0.73% | -58.5% |
| Q2 2020 | $8,505,000 | +31.9% | 108,734 | -25.0% | 1.76% | +27.8% |
| Q1 2020 | $6,446,000 | -29.9% | 145,072 | -32.6% | 1.37% | -6.7% |
| Q4 2019 | $9,191,000 | +24.2% | 215,196 | +24.4% | 1.47% | +17.8% |
| Q3 2019 | $7,400,000 | +46.3% | 172,978 | +117.2% | 1.25% | +53.8% |
| Q2 2019 | $5,058,000 | +10.6% | 79,653 | +20.8% | 0.81% | +10.9% |
| Q1 2019 | $4,573,000 | +1214.1% | 65,935 | +724.2% | 0.73% | +1142.4% |
| Q4 2018 | $348,000 | -84.5% | 8,000 | -72.8% | 0.06% | -83.2% |
| Q3 2018 | $2,242,000 | -57.1% | 29,368 | -56.8% | 0.35% | -59.5% |
| Q2 2018 | $5,228,000 | – | 68,015 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |